Integrative Medicine Alert – October 1, 2010
October 1, 2010
View Issues
-
Diet and Macular Degeneration: Eye-Opening Potential
Age-related macular degeneration (AMD) is the leading cause of blindness in adults in the United States and western Europe. Approximately 26% of adults older than 65 have some form of AMD. -
Yoga for Quality of Life and Balance in Postmenopausal Osteoporosis
Yoga and exercise are commonly recommended for patients with osteoporosis. Yoga improves balance, and both yoga and exercise improve quality of life in postmenopausal women with osteoporosis. However, the study is limited by small sample size and lack of detail in the research methodology. -
Don't Get Too Tired — It's Bad for Your Heart
Vital exhaustion predicts long-term risk for adverse cardiac events in men and women, independent of established biomedical risk factors. -
Are Carbohydrates Worse Than Saturated Fat? A New Paradigm
Replacing saturated fatty acids with carbohydrates with low glycemic index values is associated with a lower risk of myocardial infarction. -
Sobering Development: Falling Pubertal Age in Girls
In a much-publicized study on the physical maturation of young girls in three distinct areas of the United States, researchers found a persistence of early attainment of puberty in African American girls and an increased proportion of Caucasian girls who had reached puberty at ages 7 and 8 years. The study leaders delineate physical and psychological risks associated with early maturation and posit that an explanation for such findings might be some combination of increasing toxic environmental and food exposures. -
Waisting Away: Waist Circumference and Mortality
Results of this impressive observational trial suggest that waist circumference may be a more telling sign of mortality risk than BMI, especially among those whose BMI measures do not place them in the category of obesity. -
Pharmacology Watch
WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions.